Dr. Marc Dietrich, MD

deepc is a pioneering company in the realm of Radiology AI, poised to democratize access to health at scale. At the heart of our mission is ourproduct deepcOS®, an unrivaled cloud-native Radiology AI platform. With a vendor-agnostic approach, deepcOS® boasts an expansive repository of cutting-edge AI applications. This groundbreaking platform empowers radiologists to seamlessly include AI insights into their clinical workflows, ushering in a new era of patient care excellence and elevated diagnostic precision. Visit our website now or simply email us at contact@deepc.ai

Wir gestalten die Zukunft der urologischen Versorgung. Kranus Health bietet ein umfassendes Therapieangebot von der Andrologie bis zur Uro-Onkologie und erweitert aktiv sein Angebot an klinisch evidenzbasierten Behandlungen. ________________ Providing virtual care in urology. Kranus Health is providing a full range of therapies from Andrology to Uro-Oncology, actively broadening its array of virtual care journeys backed by clinical evidence. Urological conditions silently impact lives worldwide, often escaping widespread attention. Within this broad field, Andrology sheds light on the prevalent issue of erectile dysfunction, affecting a significant portion of adult males globally - 80 million in the US and EU alone. Despite its profound impact on relationships and self-esteem, it is frequently endured in silence. Prostate issues present other substantial challenges within urological health. Among them, prostate enlargement (BPH), which is the most common benign tumor found in men, affects more than 130 million in the EU and US, gradually straining healthcare systems and disrupting lives. Urology also encompasses the often-overlooked issue of incontinence, which affects roughly 200 million individuals globally, encompassing both men and women. Despite its prevalence, it remains largely sidelined in public discussions. Addressing these and other related pathologies, such as uro-oncology is crucial on a global scale. Its vital to ensure that everyone facing these challenges receives the understanding and support they need on their journey to healing.

Europe and UKs only medically approved brain stimulation headset and therapy app home treatment for Major Depressive Disorder (MDD). Treat depression. Differently. Visit for more information: flowneuroscience.com

Trialbee is revolutionizing the patient recruitment ecosystem with technology, people, and passion. The company’s vendor-agnostic Honey Platform™ is a SaaS Patient Recruitment Platform that centralizes and standardizes all recruitment activities from every source, channel, and partner from interest through enrollment – providing unprecedented transparency and actionable insights for real-time patient tracking, higher-quality referrals that reduce site burden, and robust ROI reporting. Honey is surrounded by a team of Precision Recruitment experts who meet patients where they are in their journey with data-driven modeling based on consumer behavior and other real-world data, hyper-targeted digital outreach, two-step pre-qualification, and meaningful Omnichannel partners focused on patient advocacy, community engagement, and diversity. To take control of patient recruitment for your next study, visit http://www.trialbee.com/.

deepc is a pioneering company in the realm of Radiology AI, poised to democratize access to health at scale. At the heart of our mission is ourproduct deepcOS®, an unrivaled cloud-native Radiology AI platform. With a vendor-agnostic approach, deepcOS® boasts an expansive repository of cutting-edge AI applications. This groundbreaking platform empowers radiologists to seamlessly include AI insights into their clinical workflows, ushering in a new era of patient care excellence and elevated diagnostic precision. Visit our website now or simply email us at contact@deepc.ai

Wir gestalten die Zukunft der urologischen Versorgung. Kranus Health bietet ein umfassendes Therapieangebot von der Andrologie bis zur Uro-Onkologie und erweitert aktiv sein Angebot an klinisch evidenzbasierten Behandlungen. ________________ Providing virtual care in urology. Kranus Health is providing a full range of therapies from Andrology to Uro-Oncology, actively broadening its array of virtual care journeys backed by clinical evidence. Urological conditions silently impact lives worldwide, often escaping widespread attention. Within this broad field, Andrology sheds light on the prevalent issue of erectile dysfunction, affecting a significant portion of adult males globally - 80 million in the US and EU alone. Despite its profound impact on relationships and self-esteem, it is frequently endured in silence. Prostate issues present other substantial challenges within urological health. Among them, prostate enlargement (BPH), which is the most common benign tumor found in men, affects more than 130 million in the EU and US, gradually straining healthcare systems and disrupting lives. Urology also encompasses the often-overlooked issue of incontinence, which affects roughly 200 million individuals globally, encompassing both men and women. Despite its prevalence, it remains largely sidelined in public discussions. Addressing these and other related pathologies, such as uro-oncology is crucial on a global scale. Its vital to ensure that everyone facing these challenges receives the understanding and support they need on their journey to healing.

Europe and UKs only medically approved brain stimulation headset and therapy app home treatment for Major Depressive Disorder (MDD). Treat depression. Differently. Visit for more information: flowneuroscience.com

SwissHealth Ventures investiert in Startups, die sich mit ihren Ideen für ein qualitativ hochwertiges und kosteneffizientes Gesundheitssystem einsetzen.

Lumeon helps care teams close the gap between clinical intent and operational execution at scale with our Conductor SaaS platform. Lumeon Conductor™ enhances the EMR with proprietary clinical automation to algorithmically create the optimal care plan for every patient, in real time, individualized to their specific need, taking into account social, clinical and operational factors that drive access, quality and efficiency. Lumeon transformed the care journeys of over 10M patients in the last 12 months and has proven to improve care team capacity by 60%, improve patient satisfaction by 83%, and markedly improve revenue. Lumeon’s portfolio of solutions span perioperative efficiency, management of ambulatory care, discharge planning, and acute care at home, delivering ROI in as little as three months.